Pharma Journalist -

PharmaMar has announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre (lurbinectedin), if approved, in South Korea. Under the…
Read More...

TherapeuticsMD announced a regulatory update regarding the New Drug Application (NDA) for TX-004HR, the Company’s investigational applicator-free estradiol vaginal softgel capsule for…
Read More...

FUJIFILM Corporation is to invest a total of 3.2 billion yen on its CDMO sites in the U.S.A. and the U.K. in order to accelerate the expansion of the company's business for developing…
Read More...

Europe's only Parallel Trade event returning to Central London next February. Not only will the next annual instalment feature a packed agenda that focuses on expert-led evaluations on…
Read More...

Abbott announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the company's MitraClip device for treatment of people with mitral regurgitation (MR), a…
Read More...

Artemis Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Artemisone, the Company's lead product candidate, for the treatment…
Read More...

Janssen Research & Development, LLC (Janssen) announced positive results from a randomized, placebo-controlled Phase 2 study investigating the anti-interleukin (IL)-12/23 monoclonal…
Read More...

Stealth BioTherapeutics (Stealth) announced the initiation of MMPOWER-3, a Phase 3 study evaluating the efficacy and safety of daily subcutaneous injections of elamipretide in patients…
Read More...

Boehringer Ingelheim and Dicerna Pharmaceuticals announced a research collaboration and license agreement to discover and develop novel GalXC™ RNAi therapeutics for the treatment of…
Read More...

The Canadian scientific community gathered in Ottawa this week to engage in a national dialogue on science, technology and innovation policy at the annual Canadian Science Policy…
Read More...